How Long Do Ovarian Cysts Last and When to Worry

Most ovarian cysts are functional, meaning they form as part of the normal menstrual cycle, and they typically resolve on their own within one to three menstrual cycles without any treatment. A Cochrane review of randomized trials confirmed that the majority of functional cysts disappear within a few cycles, and those that persist tend to turn out to be something other than a simple functional cyst.¹ That distinction between “functional” and “everything else” is the most important thing to grasp, because the type of cyst determines how long it lasts, whether it needs treatment, and how concerned you should be.

Functional Cysts and Their Natural Timeline

Your ovaries produce a small fluid-filled structure every cycle as part of ovulation. Sometimes the follicle that releases the egg doesn’t collapse as expected, or the corpus luteum (the structure left behind after ovulation) fills with fluid or blood. Either scenario creates a functional cyst. These are extremely common in women of reproductive age and are considered a normal byproduct of how the ovary works.

Follicular cysts, the kind that form when a follicle doesn’t release its egg, tend to be the quickest to resolve. Most shrink and vanish within four to eight weeks. Corpus luteum cysts can sometimes take a bit longer and are more prone to internal bleeding, but they also usually resolve within one to two menstrual cycles. In a study of ovarian cysts in children and adolescents, where the cysts were overwhelmingly simple and functional, spontaneous resolution took about four and a half weeks on average.² That figure is broadly consistent with what clinicians see in adult women as well.

The practical takeaway: if you’re told you have a simple ovarian cyst and you’re still menstruating, the standard approach is to wait and rescan in six to eight weeks. The vast majority of the time, the cyst will have vanished on its own by then.

When a Cyst Doesn’t Go Away

A cyst that sticks around past two or three cycles, or one that has an unusual appearance on ultrasound, is less likely to be functional. Several types of ovarian cysts are not driven by the menstrual cycle and will not resolve spontaneously.

Dermoid cysts (also called mature cystic teratomas) are among the most common non-functional ovarian masses in younger women. They contain a grab bag of tissue types like hair, fat, and even teeth, because they arise from germ cells. In premenopausal women, dermoids grow at an average rate of roughly 1.8 mm per year.³ That growth essentially stops after menopause, where the same study found the average growth rate was not meaningfully different from zero. In premenarchal girls, dermoids may grow faster, with one study reporting an average yearly growth rate of about 0.8 cm.⁴ The point is that dermoids are slow-growing but persistent. They do not shrink or disappear on their own.

Endometriomas are cysts formed when endometrial-like tissue grows on or within the ovary. Often called “chocolate cysts” because of the dark, old blood they contain, these cysts create a chronically inflamed environment inside the ovary. Their cyst fluid is rich in inflammatory molecules and reactive oxygen species, which can diffuse into surrounding ovarian tissue and interfere with normal follicle development.⁵ Endometriomas do not resolve with time and usually require a management plan that weighs symptoms, fertility goals, and the risk of surgical damage to the ovary.

Cystadenomas are benign tumors that arise from the surface cells of the ovary. They come in two main flavors: serous and mucinous. Mucinous cystadenomas tend to be larger, with a median diameter around 9 cm in one large international database, while serous cystadenomas have a median diameter around 7 cm.⁶ These masses are benign but won’t go away without surgical removal, and their size alone can cause symptoms like pressure, bloating, and pain.

The Birth Control Pill Misconception

One of the most persistent myths around ovarian cysts is that going on combined oral contraceptives will make an existing functional cyst dissolve faster. This has been tested in multiple randomized trials, and the evidence is clear: the pill does not speed up resolution of a functional cyst that has already formed. A Cochrane systematic review found this held true for cysts that arose spontaneously and for those that developed after fertility treatments.¹ Combined oral contraceptives can help prevent new functional cysts from forming by suppressing ovulation, which is why some clinicians prescribe them for women who get recurrent cysts. But if you already have a cyst, starting the pill won’t make it go away any faster than doing nothing.

Warning Signs That Need Urgent Attention

Most ovarian cysts cause no symptoms and are found incidentally during imaging for something else. But certain complications are genuine emergencies.

Ovarian torsion happens when the ovary (often weighed down by a cyst) twists on its supporting ligaments, cutting off blood supply. The main risk factor is having an ovarian mass, and torsion occurs in roughly 2% to 15% of patients who end up having surgery for an adnexal mass.⁷ The hallmark symptom is sudden, severe one-sided pelvic pain, frequently accompanied by nausea and vomiting. Torsion is a surgical emergency because a prolonged loss of blood flow can kill the ovary. If you experience sudden sharp pain that makes you double over, especially if you know you have an existing cyst, get to an emergency room quickly.

Cyst rupture is another complication, and how dangerous it is depends entirely on how much bleeding follows. Functional cysts, particularly corpus luteum cysts, are highly vascular and more prone to significant bleeding when they rupture.⁸ Many ruptured cysts cause a brief spike of pain and then settle down without intervention. But when a rupture causes significant internal bleeding, blood can collect in the abdominal cavity, a condition called hemoperitoneum. One case involved a 22-year-old who came to the emergency department with lower abdominal pain and was found to have a ruptured hemorrhagic corpus luteum cyst with enough internal bleeding to require laparoscopic surgery.⁹ In stable patients, conservative management with monitoring and pain relief is often enough. Surgery is reserved for cases where bleeding is ongoing or the patient becomes unstable.⁸

Bleeding disorders add a layer of risk. One case report described a 30-year-old woman with type 3 von Willebrand disease who developed a large hemoperitoneum from a ruptured hemorrhagic ovarian cyst. Despite the severity, she was managed without surgery using clotting factor replacement and transfusions, partly because surgery itself carries a high bleeding risk in her condition.¹⁰ If you have a known bleeding disorder, mention it to your gynecologist so your monitoring plan can account for it.

Symptoms that should prompt you to seek care urgently include sudden and severe pelvic pain (especially one-sided), pain accompanied by nausea or vomiting, feeling dizzy or faint (a sign of possible significant blood loss), fever, or rapid breathing. Mild, intermittent pelvic aching in someone with a known small cyst is generally not alarming, but a dramatic change in pain quality or intensity is.

Ovarian Cysts After Menopause

Finding an ovarian cyst after menopause used to be treated with far more alarm than it probably deserves, at least for simple cysts. A meta-analysis pooling twelve studies and over 1,500 cysts found that simple ovarian cysts in postmenopausal women were most likely to either stay the same size or disappear entirely during follow-up. About 39% remained unchanged, about 34% resolved on their own, and the malignancy rate was approximately 1 in 10,000.¹¹ The roughly 19% surgery rate reported in that analysis was driven mostly by patient preference rather than clinical necessity.

A separate large study followed over 4,000 older patients with stable adnexal masses (average age 61, average mass size about 3.8 cm). Over a median follow-up of nearly four years, only 11 cancers were detected, giving an absolute cancer risk of 0.27%. What was particularly reassuring was that cancer risk dropped with longer stability: masses that had been unchanged for more than a year had essentially zero new cancer diagnoses during follow-up.¹² So if a postmenopausal cyst looks simple on ultrasound and hasn’t changed after a year of monitoring, the cancer risk is very low.

The caveat is that “simple” is doing heavy lifting in that reassurance. A cyst that has solid components, thick walls, internal blood flow on Doppler, or irregular surfaces is a different story and needs a more thorough workup.

How Doctors Decide What Needs Further Workup

Not every ovarian cyst gets the same response. Clinicians increasingly use structured systems to classify cysts based on their ultrasound features and assign a risk level. The most widely adopted is the O-RADS (Ovarian-Adnexal Reporting and Data System) classification, which scores cysts from 1 (normal ovary, definitively not a cyst) through 5 (high risk of malignancy). A meta-analysis of studies evaluating O-RADS ultrasound found a pooled sensitivity of about 94% and a specificity of about 81% for distinguishing benign from malignant masses.¹³ A multicenter study testing a simplified scoring system alongside O-RADS found similarly strong diagnostic accuracy, with specificities above 85% for both approaches.¹⁴

When ultrasound raises concern, blood tests can help. CA-125 is the most familiar ovarian cancer marker, but it has limitations, particularly in premenopausal women where it can be elevated by endometriosis, fibroids, or even menstruation. Newer algorithms combine CA-125 with a marker called HE4 to improve accuracy. In one diagnostic accuracy study, the ROMA algorithm (which combines both markers) achieved the highest overall sensitivity at about 85%, while CA-125 alone had the highest specificity at about 94%. In premenopausal women specifically, HE4 stood out with a specificity above 98%.¹⁵ These blood tests are not screening tools for the general population. They’re used when imaging has already flagged something that warrants further investigation.

Ovarian Cysts in Children and Adolescents

Ovarian cysts occur at all ages, including in newborns and young girls. Large cysts tend to peak in the first year of life (often detected prenatally or shortly after birth) and again around menarche as the hormonal system ramps up.¹⁶ The vast majority of ovarian cysts in this age group are benign. In one series of 144 children and adolescents with ovarian cysts, all cysts that went to surgery turned out to be benign on pathological examination, and most resolved without surgery. About 30% of girls presented with pain, while the rest had cysts found incidentally.²

Surgery in young patients is reserved for complex-appearing cysts (especially suspected dermoids), cysts that are very large, severe pain, or cysts that fail to resolve. When surgery is needed, the preferred approach is laparoscopic cystectomy with ovarian preservation, removing the cyst while keeping the ovary intact. Malignancy is rare in this population but not impossible, so any solid-appearing or rapidly growing mass in a child warrants prompt evaluation.

Ovarian Cysts During Pregnancy

It’s common to discover an ovarian cyst during early pregnancy, usually on the first-trimester ultrasound. The corpus luteum of pregnancy, which produces progesterone to sustain the pregnancy until the placenta takes over, normally persists for about eight to nine weeks of gestation. When it doesn’t shrink on schedule, it can form a persistent cyst.¹⁷ Simple cysts of 3 cm or larger typically begin regressing after about ten weeks of pregnancy, with only a small fraction persisting past 14 weeks. By the end of pregnancy, more than half of cysts have either fully resolved or shrunk by at least 50%, regardless of the cyst type.

The concern with cysts during pregnancy is less about malignancy and more about mechanical complications. Large cysts can twist (torsion risk is about 1% higher in pregnant women than in non-pregnant women, with the first trimester carrying the highest risk), obstruct labor if they become impacted in the pelvis, or rupture.¹⁷ Most pregnancy-related cysts are managed with watchful waiting, but surgery during pregnancy is considered if torsion is suspected, the cyst is very large and growing, or there are concerning features on imaging. The second trimester is the preferred window for any necessary surgery, as organogenesis is complete and the uterus is not yet large enough to limit surgical access.

What Surgery Does to Ovarian Reserve

One issue that deserves attention, particularly for women who want to have children in the future, is the impact of cyst removal on ovarian reserve. Even when a surgeon carefully removes just the cyst wall and preserves the ovary, some healthy ovarian tissue is inevitably lost. This matters because each ovary has a finite number of eggs.

Anti-Müllerian hormone (AMH), a blood marker of ovarian reserve, drops after cystectomy. In one study comparing women who had laparoscopic surgery for endometriomas with women who had ovarian surgery for non-ovarian conditions, AMH levels fell in both groups in the first weeks after surgery. By six months, the control group’s AMH had recovered to baseline, but the endometrioma group’s AMH had not.¹⁸ Endometrioma surgery appears to carry a greater toll on ovarian reserve than other types of benign cyst removal, likely because the inflammatory cyst wall is harder to separate cleanly from healthy tissue and more functional tissue is stripped away in the process. For women with endometriomas who plan to pursue fertility treatment, some reproductive endocrinologists recommend proceeding with egg retrieval before surgery when possible.

Regarding surgical technique, a study comparing robotic-assisted and conventional laparoscopic cystectomy found that both approaches caused a similar drop in AMH, averaging in the range of 13% to 18%.¹⁹ The technology used matters less than the surgeon’s experience and how carefully healthy tissue is preserved during the procedure.

When “Watch and Wait” Is the Right Call

The majority of ovarian cysts in reproductive-age women never need intervention. A reasonable mental framework for sorting out which cysts to worry about:

Simple, small, asymptomatic: Cysts under about 5 cm that appear purely fluid-filled and cause no symptoms are overwhelmingly benign and likely functional. A follow-up ultrasound in six to eight weeks is standard. Most will have resolved.
Persistent but simple: A simple-appearing cyst that hasn’t changed after two to three cycles is less likely to be functional and may be a cystadenoma or other benign growth. Continued monitoring or referral to a gynecologist for further assessment is appropriate.
Complex features: Cysts with solid areas, thick internal walls, irregular surfaces, or significant blood flow visible on Doppler warrant prompt evaluation, including possible blood work and specialist referral. These features raise the index of suspicion, though they still don’t guarantee malignancy.
Postmenopausal with simple appearance: As the data show, simple cysts in postmenopausal women carry an extremely low cancer risk, especially if they remain stable over time. Annual monitoring with ultrasound is a common approach.

One area where the evidence is thin is the psychological side. Many women report significant anxiety after being told they have an ovarian cyst, particularly if they’ve lost a loved one to ovarian cancer. The word “cyst” carries more emotional weight than the statistics justify for the average case. Understanding that functional cysts are a near-universal experience for menstruating women and that even persistent benign cysts are overwhelmingly non-cancerous can help calibrate that worry.

Endometriomas and the Inflammation They Leave Behind

Endometriomas deserve a special mention because they sit in a gray zone. They won’t kill you, they’re not cancerous, but they’re not harmless either. Unlike a dermoid that just quietly sits there growing at under 2 mm per year, an endometrioma actively degrades the ovarian environment around it. The inflammatory molecules and oxidative stress compounds leaking from the cyst impair follicle development in the surrounding tissue, potentially reducing egg quality even before the cyst is removed.⁵ And as noted earlier, surgical removal itself takes a bite out of ovarian reserve. This creates a genuine dilemma for women with endometriomas who are trying to conceive: the cyst damages fertility, but so does the surgery to remove it. There is no clean answer, and the decision is best made individually with a reproductive specialist who can weigh cyst size, symptoms, AMH levels, and timeline for trying to conceive.

1
PubMed Central. Oral contraceptives for functional ovarian cysts
2
PubMed. Ovarian cysts in children and adolescents: their occurrence, behavior, and management
3
PubMed. The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women
4
PubMed. Ovarian Dermoid Cyst Trajectory in Premenarchal Girls
5
PubMed Central. FOS and Other Genes Linked to Oxidative Stress Are Upregulated in Women Suffering from Endometriosis and Might Negatively Impact the Oocyte Developmental Competence During ICSI
6
PubMed Central. Imaging in gynecological disease (28): clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa
7
PubMed Central. A review of ovary torsion
8
PubMed Central. Isolated Ovarian Cyst Rupture Cause Hemoperitoneum After High-Energy Blunt Abdominal Trauma: A Case Report
9
PubMed Central. A Case of Hemorrhagic Ovarian Cyst Rupture Necessitating Surgical Intervention
10
PubMed Central. Conservative Management of Hemoperitoneum Due to a Ruptured Hemorrhagic Ovarian Cyst in Type 3 von Willebrand Disease
11
PubMed. Natural history and malignant potential of simple ovarian cysts in postmenopausal women: a systematic review and meta-analysis
12
American Journal of Obstetrics & Gynecology. Ovarian cancer risk among older patients with stable adnexal masses
13
PubMed Central. Contrast-enhanced ultrasound and Ovarian-Adnexal Reporting and Data System ultrasound classification for risk assessment of ovarian and adnexal lesions: a systematic review and meta-analysis
14
PubMed Central. A Simple O-RADS-Based Ultrasound Scoring System for Risk Stratification of Ovarian Cystic Lesions: A Multicenter Study
15
PubMed Central. Application of Serum CA125, HE4, ROMA, and CPH-I in the Preoperative Differentiation of Ovarian Tumors: A Diagnostic Accuracy Study
16
The Obstetrician & Gynaecologist. Management of ovarian cysts in children and adolescents
17
Indian Journal of Obstetrics and Gynecology Research. A case series on navigating ovarian cysts during pregnancy assess the outcomes
18
PubMed Central. Antimullerian Hormone Changes after Laparoscopic Ovarian Cystectomy for Endometrioma Compared with the Nonovarian Conditions
19
Scientific Reports. Changes in anti-Müllerian hormone values for ovarian reserve after minimally invasive benign ovarian cystectomy: comparison of the Da Vinci robotic systems (Xi and SP) and the laparoscopic system